Related Experiment Video

Updated: Jun 6, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

Complications following ventriculo-peritoneal and subsequent ventriculo-atrial shunting resolved by third

Xiao-Jun Wu1, Chun Luo, Zhengyang Liu

  • 1Department of Neurosurgery, Changzheng Hospital, Shanghai 200003, China.

British Journal of Neurosurgery
|December 17, 2010
PubMed

Insights

Shunt rejection and thrombosis are rare complications of hydrocephalus treatment. This case study details the first instance of both occurring in the same patient following ventriculo-peritoneal and ventriculo-atrial shunt placement.

Area of Science:

  • Neurosurgery
  • Medical device complications
  • Hydrocephalus management

Background:

  • Ventriculo-peritoneal (VP) shunts are the primary treatment for hydrocephalus.
  • Complications like shunt hardware rejection, thrombosis, and embolism are infrequent.
  • Ventriculo-atrial (VA) shunts also carry risks of thrombus and embolism.

Observation:

  • A single patient experienced complications with both VP and VA shunt systems.
  • The patient presented with shunt hardware rejection.
  • Thrombosis was also observed in the shunt system.

Findings:

  • This is the first reported case of simultaneous rejection and thrombosis in both VP and VA shunts within the same patient.
  • The study highlights the potential for complex shunt-related complications.
  • It underscores the need for vigilance in monitoring patients with multiple shunt systems.

Implications:

  • Findings suggest a need for further investigation into the mechanisms of shunt failure.
  • Clinical practice may require enhanced monitoring protocols for patients with VP and VA shunts.
  • This case contributes to understanding rare adverse events in neurosurgical interventions.

More Related Videos

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...